Kristopher Jonas: Why Donors Show Up and Why It All Matters
Kristopher Jonas, Chief Executive Officer/President at Proesis Biologics, shared a post on LinkedIn:
”This recent piece from Peter Jaworski that sparked a different reflection for me.
In plasma, we spend a lot of time talking about why people donate.
But the truth is, people show up for different reasons. And, they’re all valid.
- Some are motivated by helping patients
- Some are motivated by the compensation
- Some are in between
Here’s the part that matters:
Our responsibility isn’t to judge the reason. It’s to respect the decision.
Because regardless of why someone walks through the door…they are contributing to a system that patients depend on.
And that deserves to be met with:
- Respect
- Dignity
- Appreciation
Every single time.
If we want to build a sustainable plasma supply, this principle has to be foundational:
- Fierce donor advocacy means showing up for the donor, without conditions.
- Not when it’s convenient.
- Not when it fits a narrative.
- Every time.
That’s how trust is built.
And in this industry, trust is everything.”

Stay updated with Hemostasis Today.
-
Mar 31, 2026, 14:50Heghine Khachatryan: Microthrombosis and the ‘Silent Brain Injury’ Paradigm
-
Mar 31, 2026, 14:39Samuele Takeshita: Future Perspectives on Gene Therapy Access Through Hemophilia and Sickle Cell Disease
-
Mar 31, 2026, 14:20Dear Thamasucharit: Why Hemostasis Testing and Bleeding Disorder Awareness Matter More Than You Think
-
Mar 31, 2026, 13:49New Researchs at ACC26 on Everyday Clinical Decisions – The Lancet Group
-
Mar 31, 2026, 12:58Akshat Jain: The Invisible Struggles of Living with Von Willebrand Disease
-
Mar 31, 2026, 12:50Emmanuele Kouvousis: DOAC Dose Adjustments for Older Patients
-
Mar 31, 2026, 12:34How Clinicians Prioritize Factors in Red Blood Cell Transfusions While Following Guidelines – AABB
-
Mar 31, 2026, 12:13Tareq Abadl: What if a Hospital Bacterium Can Survive on Dry Surfaces for Days to Weeks?
-
Mar 31, 2026, 11:35Lale Tokgözoğlu: Significant CV Benefit of Lowering LDL to 44 mg/dL in Diabetes